The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 23, 2018

Filed:

Jul. 28, 2015
Applicant:

Pharmabcine Inc., Daejeon, KR;

Inventors:

Jinsang Yoo, Daejeon, KR;

Ju Ryoung Nam, Daejeon, KR;

Jin San Yoo, Daejeon, KR;

Sung-Woo Kim, Daejeon, KR;

Weon Sup Lee, Daejeon, KR;

Sang Ryeol Shim, Daejeon, KR;

Sang Soon Byun, Daejeon, KR;

Miju Park, Daejeon, KR;

Hyuk Joon Lee, Daejeon, KR;

Do Yun Kim, Chungcheongbuk-do, KR;

Yeon Ju Kim, Daejeon, KR;

Mi Ae Jeon, Daejeon, KR;

Jinhee Choi, Daejeon, KR;

Youngae Lee, Daejeon, KR;

Kyoung Hee Nahm, Daejeon, KR;

Boyoung Jeong, Daejeon, KR;

Seon Young Lee, Seoul, KR;

Jong Geun Jeong, Daejeon, KR;

Jae Bong Yoon, Daejeon, KR;

Nam Ye Kim, Daejeon, KR;

Seon Hwan Oh, Daejeon, KR;

Eun Hee Lee, Daejeon, KR;

Ji Hye Jeong, Daejeon, KR;

Assignee:

PHARMABCINE INC., Daejeon, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/32 (2006.01);
U.S. Cl.
CPC ...
C07K 16/32 (2013.01); A61K 2039/505 (2013.01); C07K 2317/622 (2013.01);
Abstract

Provided are an antibody specifically bound to c-Met (c-Met-specific antibody) or fragments thereof, and more specifically, a fully human antibody having high affinity and specificity to c-Met isolated from human Fv(ScFv) phage library, a polynucleotide encoding the antibody, a recombinant vector containing the polynucleotide, a cell transformed with the recombinant vector, and a method of producing the c-Met-specific antibody by culturing the cell, wherein the c-Met-specific antibody may effectively control activity of c-Met in vivo.


Find Patent Forward Citations

Loading…